Teva Pharmaceuticals USA recalls Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), R…

Recall date

March 11, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1006-2019

FDA classification

Class III

Brand / firm

Teva Pharmaceuticals USA

Sold / distributed

Nationwide in the United States.

Why it was recalled

Subpotent Drug.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93